2/2/24 19:03  | 2/1/24  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 16 | 1.04 | 0 | 15 | 1 | 1,142 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/2/24 19:03  | 2/1/24  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S.d | -229 | 15.29 | 0 | -15 | -1 | 1,142 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/24 18:15  | 1/22/24  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 101 | 1.03 | 0 | 98 | 9 | 1,148 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/5/24 19:18  | 1/4/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | M.d | 249 | 2.34 | 0 | 106 | 90 | 224 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/5/24 19:18  | 1/4/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S.d | -1,670 | 15.70 | 0 | -106 | -32 | 224 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/24 17:05  | 1/2/24  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 16 | 1.04 | 0 | 15 | 1 | 1,050 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/4/24 17:05  | 1/2/24  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S.d | -235 | 15.67 | 0 | -15 | -1 | 1,050 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/22/23 18:27  | 12/20/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S.dm | -2,351 | 15.44 | 0 | -152 | -13 | 1,050 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/22/23 18:27  | 12/21/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 225 | 1.36 | 0 | 166 | 19 | 1,050 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/22/23 18:26  | 12/20/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Russo Thomas Joseph | WA | O | CFO | S | -235 | 15.46 | 0 | -15 | -29 | 38 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/22/23 18:25  | 12/20/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S | -184 | 15.46 | 0 | -12 | -5 | 224 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/22/23 18:24  | 12/20/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -123 | 15.46 | 0 | -8 | -6 | 131 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/15/23 19:35  | 12/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -140 | 16.01 | 0 | -9 | -6 | 131 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/1/23 20:54  | 8/1/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 3 | 0.8400 | 0 | 3 | 0 | 1,037 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/1/23 20:32  | 7/31/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S | -29 | 8.86 | 0 | -3 | -1 | 236 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/1/23 20:30  | 7/31/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S | -104 | 8.86 | 0 | -12 | -1 | 1,034 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/1/23 20:28  | 7/31/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Russo Thomas Joseph | WA | O | CFO | S | -27 | 8.86 | 0 | -3 | -6 | 46 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/1/23 20:24  | 7/31/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -17 | 8.86 | 0 | -2 | -1 | 140 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/3/23 19:43  | 7/3/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | M.d | 17 | 1.04 | 0 | 16 | 6 | 293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/3/23 19:43  | 7/3/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | S.d | -145 | 8.85 | 0 | -16 | -5 | 293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/25/23 19:39  | 5/23/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -100 | 10.00 | 0 | -10 | -7 | 142 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/23 19:12  | 4/3/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | M.d | 21 | 1.04 | 0 | 20 | 8 | 293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/23 19:12  | 4/3/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | S.d | -124 | 6.09 | 0 | -20 | -7 | 293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/8/23 17:45  | 3/6/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -39 | 7.75 | 0 | -5 | -3 | 152 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/16/23 20:00  | 2/15/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 11 | 1.04 | 0 | 11 | 1 | 1,045 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 20:12  | 2/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Bekiroglu Elizabeth | WA | O | GC,Corp. | S | -63 | 10.69 | 0 | -6 | -5 | 103 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 20:09  | 2/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S | -80 | 10.69 | 0 | -8 | -1 | 1,035 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 20:07  | 2/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | S.m | -50 | 10.33 | 0 | -5 | -2 | 293 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 20:04  | 2/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Russo Thomas Joseph | WA | O | CFO | S | -20 | 10.69 | 0 | -2 | -4 | 49 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 19:58  | 2/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S | -19 | 10.69 | 0 | -2 | -1 | 239 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/15/23 19:56  | 2/13/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -18 | 10.69 | 0 | -2 | -1 | 157 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/23 16:19  | 1/30/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | M.d | 21 | 0.8400 | 0 | 25 | 19 | 157 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/27/23 17:02  | 1/25/23  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 13 | 1.00 | 0 | 13 | 1 | 1,042 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/23/22 19:00  | 12/21/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S.d | -598 | 8.96 | 0 | -67 | -6 | 1,029 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/23/22 19:00  | 12/23/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 12 | 0.8400 | 0 | 14 | 1 | 1,029 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
12/16/22 18:36  | 12/15/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | S | -219 | 11.14 | 0 | -20 | -6 | 296 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
9/9/22 18:44  | 9/8/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Bekiroglu Elizabeth | WA | O | GC,Corp. | S | -9 | 4.87 | 0 | -2 | -2 | 109 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/22 21:47  | 7/29/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | S.m | -77 | 6.75 | 0 | -11 | -1 | 1,082 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/22 21:43  | 7/29/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Russo Thomas Joseph | WA | O | CFO | S.m | -20 | 6.75 | 0 | -3 | -6 | 49 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/22 21:42  | 7/29/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Holtzman Douglas | WA | O | Chief Sc | S.m | -69 | 6.67 | 0 | -10 | -3 | 316 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/22 21:40  | 7/29/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Richardson Charles E | WA | O | SVP,Tech | S.m | -15 | 6.75 | 0 | -2 | -1 | 165 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/22 21:37  | 7/29/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | S.m | -22 | 6.75 | 0 | -3 | -1 | 239 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/22 21:34  | 7/29/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S.m | -12 | 6.75 | 0 | -2 | -1 | 132 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/6/22 18:53  | 7/1/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 6 | 0.8400 | 0 | 7 | 1 | 1,093 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/5/22 16:10  | 4/1/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | McDade Mark | WA | D |  | P | 300 | 7.10 | 0 | 42 | 1 | 3,560 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/30/22 18:42  | 3/28/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 4 | 0.8400 | 0 | 5 | 0 | 1,010 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/30/22 16:31  | 3/28/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT |  | P.m | 837 | 4.54 | 0 | 184 | 3 | 5,964 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/22/22 16:36  | 3/18/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | M.d | 30 | 0.8400 | 0 | 35 | 36 | 134 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/9/22 17:34  | 3/7/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | S | -172 | 17.16 | 0 | -10 | -9 | 98 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/16/22 17:22  | 2/14/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Richardson Charles E | WA | O | SVP,Tech | M.d | 62 | 0.8571 | 0 | 73 | 77 | 167 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/4/22 18:25  | 2/2/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | M.d | 52 | 0.9877 | 0 | 53 | 31 | 221 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/28/22 18:04  | 1/26/22  | ICVX | Health | BioPrd | Biological Products, (No Diag | Simpson Adam K. | WA | DO | CEO | M.d | 91 | 1.00 | 0 | 91 | 36 | 345 | M |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
11/17/21 17:13  | 11/15/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Cearley Cassia | WA | O | Chief Bu | M.d | 19 | 0.8300 | 0 | 23 | 36 | 85 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 18:20  | 8/2/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Nanodimension Iii, L.P. | E9 | H | Former 1 | P.d | 2,000 | 15.00 | 0 | 133 | 5 | 2,883 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/21 16:31  | 8/2/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT |  | P.d | 40,000 | 15.00 | 0 | 2,667 |  | 639 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/3/21 18:56  | 8/2/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Gould Terry P | WA | D |  | P.d | 2,000 | 15.00 | 0 | 133 | 108 | 257 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/3/21 18:24  | 8/2/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Adams Street Partners LLC | IL | H | Former 1 | P.d | 2,000 | 15.00 | 0 | 133 | 108 | 257 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/21 21:27  | 8/2/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Qiming U.S. Healthcare Fund Ii, L.P. | WA | H | Former 1 | P.d | 3,320 | 15.00 | 0 | 221 | 7 | 3,524 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/21 21:20  | 8/2/21  | ICVX | Health | BioPrd | Biological Products, (No Diag | Kanesa-Thasan Niranjan | WA | O | Chief Me | P | 100 | 15.00 | 0 | 7 | 4 | 169 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/2/21 20:34  | 8/2/21  | ICVX | Health | Drug | Pharmaceutical Preparations | Sanofi | I0 | T |  | P.d | 1,000 | 15.00 | 0 | 67 | 2 | 3,155 | I |  |  |  |  |  |  |  |  |  |  |  |  |  |  |